IN2014MN02675A - - Google Patents
Info
- Publication number
- IN2014MN02675A IN2014MN02675A IN2675MUN2014A IN2014MN02675A IN 2014MN02675 A IN2014MN02675 A IN 2014MN02675A IN 2675MUN2014 A IN2675MUN2014 A IN 2675MUN2014A IN 2014MN02675 A IN2014MN02675 A IN 2014MN02675A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201200810A ES2442242B1 (es) | 2012-08-09 | 2012-08-09 | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. |
PCT/ES2013/000176 WO2014023860A1 (es) | 2012-08-09 | 2013-07-19 | Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02675A true IN2014MN02675A (es) | 2015-08-28 |
Family
ID=49111229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2675MUN2014 IN2014MN02675A (es) | 2012-08-09 | 2014-12-31 |
Country Status (17)
Country | Link |
---|---|
US (2) | US20140044795A1 (es) |
EP (1) | EP2883569B1 (es) |
JP (1) | JP6339568B2 (es) |
KR (1) | KR102149162B1 (es) |
CN (1) | CN104519961A (es) |
AR (1) | AR092086A1 (es) |
BR (1) | BR112015002760A2 (es) |
CA (1) | CA2881075A1 (es) |
CL (1) | CL2014003510A1 (es) |
CO (1) | CO7170177A2 (es) |
ES (2) | ES2442242B1 (es) |
IN (1) | IN2014MN02675A (es) |
MX (1) | MX357828B (es) |
PE (1) | PE20150616A1 (es) |
RU (1) | RU2696497C2 (es) |
TW (1) | TWI649084B (es) |
WO (1) | WO2014023860A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2016003282A1 (es) | 2016-12-21 | 2017-08-18 | Univ Chile | Virus aav/igf2, método de tratamiento genético y su uso en enfermedades relacionadas con mal plegamiento de proteínas tal como la enfermedad de huntington |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002531489A (ja) * | 1998-12-09 | 2002-09-24 | カイロン コーポレイション | 中枢神経系への神経栄養剤の投与 |
AR022333A1 (es) | 1999-01-26 | 2002-09-04 | Anitua Aldecoa Eduardo | Regenerador de tejido oseo |
US6811777B2 (en) * | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
ES2221770B2 (es) | 2002-04-19 | 2006-07-16 | Eduardo Anitua Aldecoa | Metodo de preparacion de un compuesto para la regeneracion de tejidos. |
US20060004189A1 (en) * | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
EP2179741B1 (en) * | 2005-08-26 | 2014-10-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treatment of headaches by administraton of oxytocin |
EP2152240A4 (en) * | 2007-06-08 | 2012-05-09 | Healthpartners Res Foundation | PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM |
ES2333498B1 (es) * | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
BRPI0816784A8 (pt) * | 2007-09-14 | 2016-01-19 | Scil Tech Gmbh | Fatores neuro-endócrinos para o tratamento de doenças degenerativas |
PL2430977T3 (pl) | 2009-05-14 | 2020-08-24 | Biotechnology Institute, I Mas D, S.L. | Sposób preparowania co najmniej jednego związku z krwi i urządzenie do pobierania próbek do stosowania podczas realizacji wspomnianego sposobu |
KR101114712B1 (ko) * | 2009-10-23 | 2012-02-29 | 세원셀론텍(주) | 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(prp)을 활성화하여 조직재생을 유도하는 조성물의 제조방법 |
ES2369945B1 (es) | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento. |
-
2012
- 2012-08-09 ES ES201200810A patent/ES2442242B1/es not_active Expired - Fee Related
-
2013
- 2013-07-19 EP EP13756518.0A patent/EP2883569B1/en not_active Not-in-force
- 2013-07-19 CN CN201380041280.4A patent/CN104519961A/zh active Pending
- 2013-07-19 TW TW102125858A patent/TWI649084B/zh not_active IP Right Cessation
- 2013-07-19 JP JP2015525915A patent/JP6339568B2/ja not_active Expired - Fee Related
- 2013-07-19 BR BR112015002760A patent/BR112015002760A2/pt not_active Application Discontinuation
- 2013-07-19 PE PE2015000116A patent/PE20150616A1/es not_active Application Discontinuation
- 2013-07-19 CA CA2881075A patent/CA2881075A1/en not_active Abandoned
- 2013-07-19 WO PCT/ES2013/000176 patent/WO2014023860A1/es active Application Filing
- 2013-07-19 ES ES13756518.0T patent/ES2662385T3/es active Active
- 2013-07-19 KR KR1020157001551A patent/KR102149162B1/ko active IP Right Grant
- 2013-07-19 RU RU2015104076A patent/RU2696497C2/ru active
- 2013-07-19 MX MX2015001677A patent/MX357828B/es active IP Right Grant
- 2013-08-08 US US13/962,340 patent/US20140044795A1/en not_active Abandoned
- 2013-08-08 AR ARP130102835A patent/AR092086A1/es unknown
-
2014
- 2014-12-23 CL CL2014003510A patent/CL2014003510A1/es unknown
- 2014-12-31 IN IN2675MUN2014 patent/IN2014MN02675A/en unknown
-
2015
- 2015-01-20 CO CO15010369A patent/CO7170177A2/es unknown
-
2016
- 2016-03-08 US US15/063,969 patent/US20160184360A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CO7170177A2 (es) | 2015-01-28 |
EP2883569A1 (en) | 2015-06-17 |
KR20150040860A (ko) | 2015-04-15 |
ES2662385T3 (es) | 2018-04-06 |
EP2883569B1 (en) | 2017-12-20 |
CN104519961A (zh) | 2015-04-15 |
CA2881075A1 (en) | 2014-02-13 |
KR102149162B1 (ko) | 2020-08-31 |
MX357828B (es) | 2018-07-25 |
US20140044795A1 (en) | 2014-02-13 |
PE20150616A1 (es) | 2015-05-25 |
ES2442242B1 (es) | 2014-11-25 |
JP2015524464A (ja) | 2015-08-24 |
CL2014003510A1 (es) | 2015-05-04 |
RU2696497C2 (ru) | 2019-08-02 |
JP6339568B2 (ja) | 2018-06-06 |
MX2015001677A (es) | 2015-04-10 |
RU2015104076A (ru) | 2016-09-27 |
WO2014023860A1 (es) | 2014-02-13 |
BR112015002760A2 (pt) | 2020-04-22 |
ES2442242A1 (es) | 2014-02-10 |
AR092086A1 (es) | 2015-03-25 |
US20160184360A1 (en) | 2016-06-30 |
TW201408310A (zh) | 2014-03-01 |
TWI649084B (zh) | 2019-02-01 |